 The goal of this research is to examine the current state of female representation in Phase 1 and 2 clinical trials and geriatric inclusion in Phase 3 clinical trials. Preliminary findings indicate that efforts to include female subjects may be effective in the subset of studies that reported their results. This article was offered by Jacqueline Chen, Caitlyn Park, Sun Young-A and others.